Fig. 3From: The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysisQuarterly DDD evolution of filgrastim (L03AA02) biosimilars over time, between January 2013 and August 2021Back to article page